Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2511-2516
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2511
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2511
Table 3 Association between high and low serum endomysial and transglutaminase 2 antibody values and small-bowel mucosal morphology
| EmA (L) | TG2-ab(U/L) | |||
| Low 1:5-200 | High 1:≥500 | Low 5.0-29.9 | High≥30 | |
| n = 227, % | n = 156, % | n = 146, % | n = 169, % | |
| Marsh 0 | 5 | 1 | 4 | 1 |
| MarshI-II | 16 | 5 | 16 | 5 |
| Marsh IIIa | 22 | 13 | 24 | 12 |
| Marsh IIIb | 28 | 29 | 31 | 28 |
| Marsh IIIc | 29 | 52 | 25 | 53 |
| P < 0.001 | P < 0.001 | |||
- Citation: Kurppa K, Räsänen T, Collin P, Iltanen S, Huhtala H, Ashorn M, Saavalainen P, Haimila K, Partanen J, Mäki M, Kaukinen K. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World J Gastroenterol 2012; 18(20): 2511-2516
- URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2511